Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1230555.RALyCSvN2TDfKw1y9iYwfRtEYLlnYfQMa2-bAZpEhbbF8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1230555.RALyCSvN2TDfKw1y9iYwfRtEYLlnYfQMa2-bAZpEhbbF8130_assertion type Assertion NP1230555.RALyCSvN2TDfKw1y9iYwfRtEYLlnYfQMa2-bAZpEhbbF8130_head.
- NP1230555.RALyCSvN2TDfKw1y9iYwfRtEYLlnYfQMa2-bAZpEhbbF8130_assertion description "[While SNP309G enhances Sp1 transcription factor binding and MDM2 transcription, SNP285C antagonizes Sp1 binding and reduces the risk of breast-, ovary- and endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1230555.RALyCSvN2TDfKw1y9iYwfRtEYLlnYfQMa2-bAZpEhbbF8130_provenance.
- NP1230555.RALyCSvN2TDfKw1y9iYwfRtEYLlnYfQMa2-bAZpEhbbF8130_assertion evidence source_evidence_literature NP1230555.RALyCSvN2TDfKw1y9iYwfRtEYLlnYfQMa2-bAZpEhbbF8130_provenance.
- NP1230555.RALyCSvN2TDfKw1y9iYwfRtEYLlnYfQMa2-bAZpEhbbF8130_assertion SIO_000772 25327560 NP1230555.RALyCSvN2TDfKw1y9iYwfRtEYLlnYfQMa2-bAZpEhbbF8130_provenance.
- NP1230555.RALyCSvN2TDfKw1y9iYwfRtEYLlnYfQMa2-bAZpEhbbF8130_assertion wasDerivedFrom befree-2016 NP1230555.RALyCSvN2TDfKw1y9iYwfRtEYLlnYfQMa2-bAZpEhbbF8130_provenance.
- NP1230555.RALyCSvN2TDfKw1y9iYwfRtEYLlnYfQMa2-bAZpEhbbF8130_assertion wasGeneratedBy ECO_0000203 NP1230555.RALyCSvN2TDfKw1y9iYwfRtEYLlnYfQMa2-bAZpEhbbF8130_provenance.